Stop by booth #1440 at AMP 2022 to see how careviso can improve lab TAT, RCM, and more! Chat with our account managers and watch a demo.
Continue readingJoin Us at AMP 2022
Breast Cancer Awareness Month
Thousands of people are affected by breast cancer each year. This month’s blog emphasizes statistics, risk factors, and screenings.
Continue readingcareviso Raises Over $17 million in Series B Funding to Enhance Transparency and Access for Diagnostic Testing
careviso, the market leader in molecular diagnostic patient access technology, announced it has raised over $17 million in Series B funding.
Continue readingLabs Pivoting from COVID
Our latest article discusses the impact of the COVID-19 pandemic on laboratories and where laboratories are heading from here.
Continue readingGynecological Cancer Awareness Month
September is Gynecological Cancer Awareness Month! Discover the different types, warning signs, and prevention tips.
Continue readingNational Eye Exam Month
August is National Eye Exam Month! Read about the most common eye diseases and the importance of eye exams.
Continue readingIntroducing careviso: CMT Solutions Unveils New Brand Identity
CMT Solutions announces new name: careviso. The new brand encompasses company’s expansion of services and product offerings beyond prior authorizations.
Continue readingMen’s Health Month 2022
June is Men’s Health Month! Learn more about the unique risks men face when seeking and receiving care, and get tips on how to avoid health complications.
Continue readingPrior Authorization Basics
Prior authorization reform basics: test, collaborate, serve the patient. Learn more about PA process and how providers can improve patient outcomes in our latest post.
Continue readingTrends in Genetic Testing
Learn about the recent testing ordering and reimbursement trends published by the Office of Inspector General.
Continue reading